Literature DB >> 18257991

Cost-effectiveness of algorithms for confirmation test of human African trypanosomiasis.

Pascal Lutumba1, Filip Meheus, Jo Robays, Constantin Miaka, Victor Kande, Philippe Büscher, Bruno Dujardin, Marleen Boelaert.   

Abstract

The control of Trypanosoma brucei gambiense human African trypanosomiasis (HAT) is compromised by low sensitivity of the routinely used parasitologic confirmation tests. More sensitive alternatives, such as mini-anion exchange centrifugation technique (mAECT) or capillary tube centrifugation (CTC), are more expensive. We used formal decision analysis to assess the cost-effectiveness of alternative HAT confirmation algorithms in terms of cost per life saved. The effectiveness of the standard method, a combination of lymph node puncture (LNP), fresh blood examination (FBE), and thick blood film (TBF), was 36.8%; the LNP-FBE-CTC-mAECT sequence reached almost 80%. The cost per person examined ranged from euro1.56 for LNP-FBE-TBF to euro2.99 for LNP-TBF-CTC-mAECT-CATT (card agglutination test for trypanosomiasis) titration. LNP-TBF-CTC-mAECT was the most cost-effective in terms of cost per life saved. HAT confirmation algorithms that incorporate concentration techniques are more effective and efficient than the algorithms that are currently and routinely used by several T.b. gambiense control programs.

Entities:  

Mesh:

Year:  2007        PMID: 18257991      PMCID: PMC2851529          DOI: 10.3201/eid1310.060358

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  24 in total

1.  Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis.

Authors:  M Boelaert; L Lynen; P Desjeux; P Van der Stuyft
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

2.  Evaluation of an EDTA version of CATT/Trypanosoma brucei gambiense for serological screening of human blood samples.

Authors:  Eddy Magnus; Veerle Lejon; Dominique Bayon; Dirk Buyse; Pere Simarro; Didier Verloo; Tony Vervoort; Resi Pansaerts; Philippe Büscher; Nestor Van Meirvenne
Journal:  Acta Trop       Date:  2002-01       Impact factor: 3.112

3.  Attitude towards CATT-positive individuals without parasitological confirmation in the African Trypanosomiasis (T.b. gambiense) focus of Quiçama (Angola).

Authors:  P P Simarro; J A Ruiz; J R Franco; T Josenando
Journal:  Trop Med Int Health       Date:  1999-12       Impact factor: 2.622

4.  [The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense].

Authors:  Pascal Lutumba; Jo Robays; Constantin Miaka; Victor Kande; Pere P Simarro; Alexandra P M Shaw; Bruno Dujardin; Marleen Boelaert
Journal:  Trop Med Int Health       Date:  2005-04       Impact factor: 2.622

5.  [Use of the CATT Testryp in screening for trypanosomiasis in Nioki, Zaire].

Authors:  J Pépin; C Guern; D Mercier; P Moore
Journal:  Ann Soc Belg Med Trop       Date:  1986-09

6.  Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy.

Authors:  J Pépin; F Milord; A Khonde; T Niyonsenga; L Loko; B Mpia
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Jul-Aug       Impact factor: 2.184

7.  Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis.

Authors:  J Blum; S Nkunku; C Burri
Journal:  Trop Med Int Health       Date:  2001-05       Impact factor: 2.622

8.  Card agglutination test for trypanosomiasis (CATT) end-dilution titer and cerebrospinal fluid cell count as predictors of human African Trypanosomiasis (Trypanosoma brucei gambiense) among serologically suspected individuals in southern Sudan.

Authors:  François Chappuis; Elisa Stivanello; Karen Adams; Solon Kidane; Anne Pittet; Patrick A Bovier
Journal:  Am J Trop Med Hyg       Date:  2004-09       Impact factor: 2.345

9.  The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo.

Authors:  Jo Robays; Miaka Mia C Bilengue; Patrick Van der Stuyft; Marleen Boelaert
Journal:  Trop Med Int Health       Date:  2004-05       Impact factor: 2.622

10.  [Evaluation of the parasitologic technics used in the diagnosis of human Trypanosoma gambiense trypanosomiasis in the Ivory Coast].

Authors:  T W Miezan; A H Meda; F Doua; P Cattand
Journal:  Bull Soc Pathol Exot       Date:  1994
View more
  13 in total

1.  Phase II evaluation of sensitivity and specificity of PCR and NASBA followed by oligochromatography for diagnosis of human African trypanosomiasis in clinical samples from D.R. Congo and Uganda.

Authors:  Enock Matovu; Claire M Mugasa; Rosine Ali Ekangu; Stijn Deborggraeve; George W Lubega; Thierry Laurent; Gerard J Schoone; Henk D Schallig; Philippe Büscher
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

Review 2.  NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness.

Authors:  Oliver Yun; Gerardo Priotto; Jacqueline Tong; Laurence Flevaud; François Chappuis
Journal:  PLoS Negl Trop Dis       Date:  2010-05-25

3.  Diagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal study.

Authors:  Stijn Deborggraeve; Veerle Lejon; Rosine Ali Ekangu; Dieudonné Mumba Ngoyi; Patient Pati Pyana; Médard Ilunga; Jean Pierre Mulunda; Philippe Büscher
Journal:  PLoS Negl Trop Dis       Date:  2011-02-22

4.  Accuracy of five algorithms to diagnose gambiense human African trypanosomiasis.

Authors:  Francesco Checchi; François Chappuis; Unni Karunakara; Gerardo Priotto; Daniel Chandramohan
Journal:  PLoS Negl Trop Dis       Date:  2011-07-05

Review 5.  A literature review of economic evaluations for a neglected tropical disease: human African trypanosomiasis ("sleeping sickness").

Authors:  C Simone Sutherland; Joshua Yukich; Ron Goeree; Fabrizio Tediosi
Journal:  PLoS Negl Trop Dis       Date:  2015-02-05

6.  Illuminating the Prevalence of Trypanosoma brucei s.l. in Glossina Using LAMP as a Tool for Xenomonitoring.

Authors:  Lucas J Cunningham; Jessica K Lingley; Lee R Haines; Joseph M Ndung'u; Stephen J Torr; Emily R Adams
Journal:  PLoS Negl Trop Dis       Date:  2016-02-18

7.  Expression of Trypanosoma brucei gambiense Antigens in Leishmania tarentolae. Potential for Use in Rapid Serodiagnostic Tests (RDTs).

Authors:  Barrie Rooney; Turid Piening; Philippe Büscher; Stijn Rogé; C Mark Smales
Journal:  PLoS Negl Trop Dis       Date:  2015-12-09

8.  A Phase III Diagnostic Accuracy Study of a Rapid Diagnostic Test for Diagnosis of Second-Stage Human African Trypanosomiasis in the Democratic Republic of the Congo.

Authors:  Marleen Boelaert; Deby Mukendi; Emmanuel Bottieau; Jean Roger Kalo Lilo; Kristien Verdonck; Luigi Minikulu; Barbara Barbé; Philippe Gillet; Cédric P Yansouni; François Chappuis; Pascal Lutumba
Journal:  EBioMedicine       Date:  2017-12-06       Impact factor: 8.143

9.  An Active Follow-up Strategy for Serological Suspects of Human African Trypanosomiasis with Negative Parasitology Set up by a Health Zone Team in the Democratic Republic of Congo.

Authors:  Matthieu Nkieri; Florent Mbo; Papy Kavunga; Pathou Nganzobo; Titus Mafolo; Chalet Selego; Eric Mwamba Miaka
Journal:  Trop Med Infect Dis       Date:  2020-04-04

10.  Cost-effectiveness of using a rapid diagnostic test to screen for human African trypanosomiasis in the Democratic Republic of the Congo.

Authors:  Paul R Bessell; Crispin Lumbala; Pascal Lutumba; Sylvain Baloji; Sylvain Biéler; Joseph M Ndung'u
Journal:  PLoS One       Date:  2018-09-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.